Description: This session from the 1983 SOA Spring Meeting discusses reversion rates and mortality on non-reverted lives, mortality experience versus mortality tables, select and ultimate term insurance products and the developing experience for term insurance.

Description: This session is about recent population experience, likely causes, probable future prospects, Industry mortality differentials and trends by product line,market and type of underwriting, What statistically credible evidence do we have for the efficacy of life insurance underwriting practices, What does the new Intercompany Standard Issues study show and Are there sound biological laws of mortality. From Record of Society of Actuaries Vol. 5, No. 4.

Description: This discussion covers an update on mortality research. Specifically, it highlights the long term conditional survival of cancer patients, recent trends in the mortality of the aged, parametric models for life insurance mortality data, and shares an exposure draft of the derivation of the 1983 table A for individual annuity valuation. From Record of the Society of Actuaries 1981, Volume 7, No. 4.

Description: While this session was billed as C-2 risk, discussion focused almost entirely on HIV and AIDS, including the history, nature, spreading and mortality of the disease, and its impact on life and health insurance underwriting, pricing, and reserves. From the 1987 Record of Society of Actuaries, Vol. 13, No. 3.

Description: This 1978 SOA session presented some provisional findings of the new Build and Blood Pressure Study. Some of the findings: 1. The average weights of men in the new study exceed the corresponding weights in the previous 1959 study by 2 to 8 pounds in the thirties, and by up to 5 pounds in the fifties. 2. The mortality ratios of overweight men are not significantly different in the new study from those in the 1959 study. 3. Markedly overweight men experienced lower mortality in the current study than in the 1959 study. 4. Men weighing 20 percent below average recorded 10 to 15 percent higher mortality in the new study than in the 1959 study. 5. Mortality of overweight women is relatively lower than that of overweight men. 6. Mortality of men with elevated systolic and diastolic pressures was appreciably lower than in the 1959 study. 7. Mortality of women with moderately elevated systolic and diastolic pressures was not significantly different from that in the 1959 study. 8. The presence of minor impairments alongside of blood pressures in excess of 150/90 usually produced significant increases in mortality.

Description: This session from the 1983 SOA Vancouver Meeting reviews the Business Mens Assurance's computerized mortality study on its reinsured business. It also discusses smoker/non-smoker mortality assumptions, surplus relief via traditional coinsurance and mod-co and TEFRA impact on reinsurance. From Record of Society of Actuaries Vol. 9, No. 3

Description: Presented at October 1985 Annual Meeting. Discusses how much of the sex mortality differential is due to smoking habits, how convincing are existing studies, what do worldwide trends in mortality suggest about the effects of smoking and on mortality, how well do insurers classify the smoking risk, and the United States Life Tables for 1979-81 paper by Myers and Bayo.

Description: In session 10PD of the Washington Annual Meeting panelists discuss current pensioner mortality information as well as projected trends. From the Record of the Society of Actuaries, Vol. 23, No. 3.

Description: This session from the 1983 SOA Hollywood, Florida Meeting discusses the Norris case, the Fair Insurance Practices Act and HR100, known as the Non-Discrimination in Insurance Act and the implications of these current developments regarding risk classification in the insurance industry and pension plans. From Record of the Society Vol. 9, No. 4

Description: 2004 SOA Annual Meeting and Exhibit, New York. This session covered the results of new experience studies for individual disability, group disability and group life, the implications of the results, and the future direction of the studies.